Biotech

All Articles

Rivus' period 2 obesity-related heart failure trial attacks endpoint

.Rivus Pharmaceuticals has plumped up the potential customers of its fat-busting, muscle-sparing dru...

Ovid halts preclinical job, IV system after soticlestat stop working

.Ovid Therapy actually disclosed final month that it was actually trimming its own head count as the...

Eli Lilly opens up $700M nucleic acid R&ampD facility in Boston Seaport

.Eli Lilly has opened a $700 thousand R&ampD facility in the Boston ma Seaport, boosting its RNA and...

Boundless Biography makes 'modest' unemployments 5 months after $100M IPO

.Merely five months after getting a $one hundred million IPO, Limitless Bio is actually actually giv...

Halda's $126M is going to progress 'hold and kill' tumor drugs

.The first phases of oncology R&ampD aren't short of interesting brand new techniques, and Halda The...

Lykos 'regrets' certainly not divulging research infractions along with publisher

.Psychopharmacology has taken three articles about midstage clinical test data analyzing Lykos Thera...

Analysts explore Avidity's DMD win, revealing nuances in information

.Avidity Biosciences impressed investors along with period 1/2 information in Duchenne muscle dystro...

Actinogen's cortisol blocker falls short phase 2 anxiety research

.Actinogen Medical's cortisol blocker has actually skipped the major endpoint of a stage 2 research ...

Bivictrix decides going personal only means to take ADC into facility

.Antibody-drug conjugates (ADCs) have been at the center of many a billion-dollar biobuck licensing ...

TPG tops up funds to $580M for assets across lifestyle scientific researches

.Property manager TPG, which has actually assisted biotechs such as Sionna Therapeutics and also San...